Related Experiment Video
Updated: Oct 25, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management
Shigeru Shibata1, Shunya Uchida1,2
1Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Insights
Hyperkalemia is common in maintenance hemodialysis (MHD) patients due to kidney dysfunction. This review covers potassium regulation, focusing on extra-renal pathways and management strategies for MHD patients.
Area of Science:
- Nephrology
- Physiology
- Internal Medicine
Background:
- Potassium is a critical intracellular cation regulating excitable cell membrane potential.
- Kidney dysfunction, common in maintenance hemodialysis (MHD) patients, disrupts potassium balance, leading to hyperkalemia.
- Comorbid conditions can alter potassium distribution, contributing to dyskalemia in MHD patients.
Purpose of the Study:
- To review potassium physiology in MHD patients, highlighting changes from normal kidney function.
- To emphasize the role of extra-renal potassium elimination, including gastrointestinal pathways.
- To summarize current management strategies for dyskalemia in MHD.
Main Methods:
- Literature review of potassium physiology in MHD patients.
- Emphasis on changes compared to individuals with normal kidney function.
- Summary of recent findings on dietary, dialysate, and pharmacological therapies.
Main Results:
- Reduced renal potassium excretion is a primary cause of hyperkalemia in MHD.
- Extra-renal potassium elimination, particularly via the gastrointestinal tract, is significant.
- Inhibitors of the renin-angiotensin-aldosterone system can impact extra-renal potassium elimination.
Conclusions:
- Understanding potassium shifts in MHD patients is crucial for managing dyskalemia.
- Extra-renal potassium elimination pathways offer therapeutic targets.
- Comprehensive management involves dietary, dialysate, and pharmacological interventions.
Abstract:
Potassium is a major intracellular cation in the body, regulating membrane potential of excitable cells, such as cardiomyocytes and skeletal muscle cells. Because the kidney plays a critical role in controlling potassium balance, the elevation in serum potassium levels is one of the most common complications in patients with maintenance hemodialysis (MHD). In addition to reduced renal potassium excretion, the alteration in body potassium distribution owing to comorbid conditions may also contribute to dyskalemia. Besides potassium elimination through hemodialysis in MHD patients, accumulating data indicate the potential importance of extra-renal elimination involving the gastrointestinal system, which can be affected by the inhibitors of the renin-angiotensin-aldosterone system. In this article, the literature on potassium physiology in MHD patients is reviewed with an emphasis on the changes from individuals with normal kidney function. This article also summarizes the findings of recent studies on dietary control, dialysate prescription, and pharmacological therapy.
Related Concept Videos
Hemodialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease IV: Nursing Management

